Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Little

Showing results (1-10 of 185) with videos related to

Pageof 19
Sort By:
Lancet (London, England)|February 8, 2003
The PROSPER trialPeter J Little
Life Sciences|April 16, 2013
GPCR responses in vascular smooth muscle can occur predominantly through dual transactivation of kinase receptors and not classical Gαq protein signalling pathwaysPeter J Little
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 26, 2020
Smad2 linker region phosphorylation is an autonomous cell signalling pathway: Implications for multiple disease pathologiesDanielle Kamato, Peter J Little
Journal of Hypertension|February 28, 2008
Another piece of cell biology in the puzzle of inflammation, glucose and diabetic vascular diseaseRodney J Dilley, Peter J Little
Thrombosis Research|June 24, 2008
Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathwaysMelanie E Ivey, Peter J Little
Medicinal Research Reviews|March 16, 2017
Atheroprotective Effects and Molecular Targets of Tanshinones Derived From Herbal Medicine DanshenJian Fang, Peter J Little, Suowen Xu
Thescientificworldjournal|April 7, 2009
Potential of small molecule protein tyrosine kinase inhibitors as immuno-modulators and inhibitors of the development of type 1 diabetesPeter J Little, Neale Cohen, Grant Morahan
Pharmacology & Therapeutics|April 23, 2011
Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosisPeter J Little, Alan Chait, Alex Bobik
Current Vascular Pharmacology|August 5, 2008
Endothelin-1 actions on vascular smooth muscle cell functions as a target for the prevention of atherosclerosisPeter J Little, Melanie E Ivey, Narin Osman
Vascular Health and Risk Management|June 23, 2007
Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosisPeter J Little, Mandy L Ballinger, Narin Osman
Pageof 19

Showing results (1-10 of 185) with videos related to

Sort By:
Pageof 19
Lancet (London, England)|February 8, 2003
The PROSPER trialPeter J Little
Life Sciences|April 16, 2013
GPCR responses in vascular smooth muscle can occur predominantly through dual transactivation of kinase receptors and not classical Gαq protein signalling pathwaysPeter J Little
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 26, 2020
Smad2 linker region phosphorylation is an autonomous cell signalling pathway: Implications for multiple disease pathologiesDanielle Kamato, Peter J Little
Journal of Hypertension|February 28, 2008
Another piece of cell biology in the puzzle of inflammation, glucose and diabetic vascular diseaseRodney J Dilley, Peter J Little
Thrombosis Research|June 24, 2008
Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathwaysMelanie E Ivey, Peter J Little
Medicinal Research Reviews|March 16, 2017
Atheroprotective Effects and Molecular Targets of Tanshinones Derived From Herbal Medicine DanshenJian Fang, Peter J Little, Suowen Xu
Thescientificworldjournal|April 7, 2009
Potential of small molecule protein tyrosine kinase inhibitors as immuno-modulators and inhibitors of the development of type 1 diabetesPeter J Little, Neale Cohen, Grant Morahan
Pharmacology & Therapeutics|April 23, 2011
Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosisPeter J Little, Alan Chait, Alex Bobik
Current Vascular Pharmacology|August 5, 2008
Endothelin-1 actions on vascular smooth muscle cell functions as a target for the prevention of atherosclerosisPeter J Little, Melanie E Ivey, Narin Osman
Vascular Health and Risk Management|June 23, 2007
Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosisPeter J Little, Mandy L Ballinger, Narin Osman
Pageof 19